Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
This page is not indexed by search engines while we improve data quality.
Mcinnes Campbell — Human Necessities
Mcinnes Campbell holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Mcinnes Campbell |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2015 |
Representative patents
Notable publications linking Mcinnes Campbell to Human Necessities.
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Recent filings
Latest patents from Mcinnes Campbell in Human Necessities.
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Fragment ligated inhibitors selective for the polo box domain of PLK1
US-9175357-B2 · Nov 3, 2015 · US
Related pages
Navigate to parent entity pages.